Abstract:Tumor-associated macrophages (TAMs) are predominantly present in the tumor microenvironment (TME) and play a crucial role in shaping the efficacy of tumor immunotherapy. These TAMs primarily exhibit a tumor-promoting M2-like phenotype, which is associated with the suppression of immune responses and facilitation of tumor progression. Interestingly, recent research has highlighted the potential of repolarizing TAMs from an M2 to a pro-inflammatory M1 status-a shift that has shown promise in impeding tumor growth and enhancing immune responsiveness. This concept is particularly intriguing as it offers a new dimension to cancer therapy by targeting the tumor microenvironment, which is a significant departure from traditional approaches that focus solely on tumor cells. However, the clinical application of TAM-modulating agents is often challenged by issues such as insufficient tumor accumulation and off-target effects, limiting their effectiveness and safety. In this regard, nanomaterials have emerged as a novel solution. They serve a dual role: as delivery vehicles that can enhance the accumulation of therapeutic agents in the tumor site and as TAM-modulators. This dual functionality of nanomaterials is a significant advancement as it addresses the key limitations of current TAM-modulating strategies and opens up new avenues for more efficient and targeted therapies. This review provides a comprehensive overview of the latest mechanisms and strategies involving nanomaterials in modulating macrophage polarization within the TME. It delves into the intricate interactions between nanomaterials and macrophages, elucidating how these interactions can be exploited to drive macrophage polarization towards a phenotype that is more conducive to anti-tumor immunity. Additionally, the review explores the burgeoning field of TAM-associated nanomedicines in combination with tumor immunotherapy. This combination approach is particularly promising as it leverages the strengths of both nanomedicine and immunotherapy, potentially leading to synergistic effects in combating cancer.

Application of Bionanomaterials in Tumor Immune Microenvironment Therapy

Application of nanomaterials in cancer immunotherapy

Biomaterials' enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment

Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy

Nanomaterial-based cancer immunotherapy: enhancing treatment strategies

Nanoengineered Targeting Strategy for Cancer Immunotherapy

Application of Cell Membrane-Coated Nanomaterials for Tumor Treatment.

Emerging biomaterials for tumor immunotherapy

The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment

Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment

Cancer immunotherapy: Classification, therapeutic mechanisms, and nanomaterial-based synergistic therapy

Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy

Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics

Intelligent nanomaterials for cancer therapy: recent progresses and future possibilities

Biomaterials tools to modulate the tumour microenvironment in immunotherapy

Emerging nanotechnological strategies to reshape tumor microenvironment for enhanced therapeutic outcomes of cancer immunotherapy.

Application of Carbon Nanomaterials to Enhancing Tumor Immunotherapy: Current Advances and Prospects

Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy

Application of nanotechnology in circumventing immunotolerance.